GSK Faces Wave Of Zofran Birth Defect Suits
GlaxoSmithKline LLC on Wednesday was hit with a complaint in California federal court tying alleged off-label promotion of anti-nausea drug Zofran to birth defects, adding to a number of similar lawsuits...To view the full article, register now.
Already a subscriber? Click here to view full article